Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Enoxaparin sodium 100mg/1ml inj pre-filled syringes
0208010D0AAAEAE
|
Enoxaparin | Enoxaparin | Cardiovascular System | 1,883 |
|
Irriclens sodium chloride 0.9% irrigation solution aerosol spray
21160000080
|
Irriclens sodium chloride 0.9% irrigation solution aerosol spray | Irrigation Solutions | Appliances | 1,880 |
|
Non-sterile drainable night drainage bag
22604886002
|
Non-sterile drainable night drainage bag | Night Drainage Bags | Incontinence Appliances | 1,879 |
|
Octasa 1g suppositories
0105010B0BIADAJ
|
Octasa | Mesalazine (Systemic) | Gastro-Intestinal System | 1,878 |
|
Absorb odour neutralising absorbent gel 3g sachets
23463374601
|
Absorb odour neutralising absorbent gel 3g sachets | Discharge Solidifying Agents | Stoma Appliances | 1,877 |
|
Indivina 2mg/5mg tablets
0604011L0BTACBG
|
Indivina | Estradiol with progestogen | Endocrine System | 1,876 |
|
Chloramphenicol 0.5% eye dps 0.5ml ud preservative free
1103010C0AAAGAG
|
Chloramphenicol (Eye) | Chloramphenicol | Eye | 1,874 |
|
LoFric Elle catheter female 10Ch-14Ch
21020001533
|
LoFric Elle catheter female 10Ch-14Ch | Catheters | Appliances | 1,874 |
|
Pelican Select convex ileostomy bag with filter, standard 12-40mm clear
23603456290
|
Pelican Select convex ileostomy bag with filter, standard 12-40mm clear | Ileostomy Bags | Stoma Appliances | 1,874 |
|
Venlablue XL 75mg capsules
0403040W0BRAAAD
|
Venlablue | Venlafaxine | Central Nervous System | 1,874 |
|
Irrigator bag
23701007008
|
Irrigator bag | Irrigation Washout Appliances | Stoma Appliances | 1,872 |
|
Synalar 0.025% cream
1304000N0BBAAAB
|
Synalar | Fluocinolone acetonide | Skin | 1,872 |
|
Ethinylestradiol 30microgram / Gestodene 75microgram tablets
0703010F0AAAEAE
|
Combined ethinylestradiol 30mcg | Combined ethinylestradiol 30mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,870 |
|
Bonjela Junior gel
1502010J0BVAAEQ
|
Bonjela | Lidocaine hydrochloride | Anaesthesia | 1,869 |
|
Ibuprofen 200mg capsules
1001010J0AAAAAA
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | 1,868 |
|
Aerobika mucus clearance device
21010220118
|
Aerobika mucus clearance device | Other Appliances | Appliances | 1,867 |
|
Aprovel 150mg tablets
0205052I0BBABAB
|
Aprovel | Irbesartan | Cardiovascular System | 1,866 |
|
Budesonide 9mg modified-release tablets
0105020A0AAAFAF
|
Budesonide (Systemic) | Budesonide | Gastro-Intestinal System | 1,866 |
|
Jobst Elvarex Soft non-standard colour for lymphoedema garment lower extremities
21270000910
|
Jobst Elvarex Soft non-standard colour for lymphoedema garment lower extremities | Lymphoedema Garments | Appliances | 1,866 |
|
AeroChamber Plus Flow-Vu Anti-Static with small mask infant 0-18 months
21010230167
|
AeroChamber Plus Flow-Vu Anti-Static with small mask infant 0-18 months | Other Appliances | Appliances | 1,864 |
|
Lynlor 5mg capsules
0407020ADBHAAAC
|
Lynlor | Oxycodone hydrochloride | Central Nervous System | 1,864 |
|
Depixol Conc 100mg/1ml solution for injection ampoules
0402020G0BBADAB
|
Depixol (Parenteral) | Flupentixol decanoate | Central Nervous System | 1,863 |
|
Fortini 1.0 Multi Fibre liquid (4 flavours)
0913021B0BCAAAB
|
Fortini RtS 1 kcal/ml milkshake lower energy with fibre | RtS 1 kcal/ml milkshake lower energy with fibre (0913021) | Nutrition and Blood | 1,863 |
|
Gazylan XL 24mg capsules
0411000F0BKACAG
|
Gazylan XL | Galantamine | Central Nervous System | 1,863 |
|
Levetiracetam 250mg granules sachets sugar free
0408010A0AAAKAK
|
Levetiracetam | Levetiracetam | Central Nervous System | 1,862 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.